Cases of severe COVID-19 remained low during the first year of the pandemic in people in France with cystic…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Some people with severe asthma, an inflammatory lung condition, carry variants of the CFTR gene that causes cystic fibrosis…
Triple combination therapies, a mix of CFTR correctors and potentiators, significantly improve lung function, reduce sweat chloride, and enhance the…
The first patient has been dosed in a Phase 1/2 clinical trial evaluating 4D-710, an investigational genetic medicine for adults…
A new online exercise and yoga program for children and adolescents living with cystic fibrosis (CF) is in development…
Survival following lung transplant due to cystic fibrosis (CF) in children ages 10 and younger was similar to survival…
The COVID-19 pandemic markedly limited exercise training and related services provided at cystic fibrosis (CF) care centers in the U.K.,…
HIT-CF, a European Union-funded research project, is working to provide personalized disease-modifying treatments to cystic fibrosis (CF) patients…
The bacterial composition within the airways of children with cystic fibrosis (CF) differs from those with primary ciliary dyskinesia…
Monocyte immune cells from bone marrow partially transplanted into a mouse model of cystic fibrosis (CF) improved survival and…